Concepedia

Manoj Chelvanambi

MC

10

Publications

841

Citations

10

H-Index

2019

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Melanoma Institute Australia

University of Pittsburgh

The University of Texas Health Science Center at Houston

University of California, San Francisco

Manoj Chelvanambi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2019–2025

10

Publications

10

Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome

Rebecca Simpson, Erin R. Shanahan, Marcel Batten et al. · Nature Medicine · 2022 · 216 citations

, , +13

STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment

Manoj Chelvanambi, Ronald J. Fecek, Jennifer L. Taylor et al. · Journal for ImmunoTherapy of Cancer · 2021 · 165 citations · Full text

Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells

Yogesh Goyal, Gianna T. Busch, Maalavika Pillai et al. · Nature · 2023 · 162 citations · Full text

, , +11

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Christopher P. Vellano, Michael G. White, Miles C. Andrews et al. · Nature · 2022 · 124 citations · Full text

, , +6

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma

Walter J. Storkus, Deena M. Maurer, Yan Lin et al. · Journal for ImmunoTherapy of Cancer · 2021 · 51 citations · Full text

Rows per page

1–5 of 10